The absence of Palbociclib medicine for about four months is suspected of having been followed by the worsening condition of a breast cancer patient, who was unable to buy the grass that costs up to 1,000 and 800 euros.

Renasenassa has announced that new metastases had appeared in her brain and that she died.

An advanced breast cancer patient and metastases in other organs have died for about four months after being left without Palbociclib therapy, due to its lack of access to the Oncology Clinic and the inability to buy it on its own, says an organisation for cancer patients.

Palbociclib, who is used in treating advanced breast cancer, was absent for about four months at the Oncology Clinic, although it is part of the Essencial List of Bars.

Patients forced to buy this bar themselves face costs of up to 1,000 and 800 euros.

In the response released Wednesday, the organisation Renesansa has announced that the patient had not been able to provide therapy because of the high price. During the period that remained untreated, new metastases appeared in her brain.

The patient who was in therapy with Palbociclib and felt good, but whom Palbociclib lacked for about four months because of the inability to secure it because of the high price of this shepherd, remained four months without therapy, hoping that he would have supplies every day. But lack of therapy brought new metastases to the brain. And… in the end, he lost his life, said the organization’s response. Security of essential drugs for oncological patients, for all, is the moral duty of anyone who has to act to prolong the lives of these patients, starting with the KKUK and the Ministry of Health. Time.